Clinical Trial

Prospective Single-Arm Clinical Trial of GO Regimen for HLH.

Name: Prospective Single-Arm Clinical Trial of GO Regimen for HLH. — clinical trial record (NCT07339345)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Record status

This record was last updated January 14, 2026 (before its estimated June 27, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study aims to investigate the efficacy and safety of Golidocitinib(GO) monotherapy in the treatment of hemophagocytic lymphohistiocytosis.

Trial Details

NCT Number	NCT07339345
Lead Sponsor	Beijing Friendship Hospital
Conditions	Lymphohistiocytosis, Hemophagocytic
Enrollment	28 participants
Start Date	2025-06-27
Primary Completion	2026-06-27 (estimated)
Study Completion	2027-06-27 (estimated)
Updated on ClinicalTrials.gov	2026-01-14